Health Care & Life Sciences » Pharmaceuticals | Prestige Brands Holdings Inc.

Prestige Brands Holdings Inc. | Income Statement

Fiscal year is April-March. All values USD Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
602
715
806
882
1,041
976
Cost of Goods Sold (COGS) incl. D&A
275
324
361
404
489
447
Gross Income
327
391
445
478
552
529
SG&A Expense
137
167
181
199
229
229
EBIT
190
224
264
279
322
300
Unusual Expense
20
16
22
23
109
234
Non Operating Income/Expense
-
1
-
52
-
1
Interest Expense
69
81
85
94
106
105
Pretax Income
102
127
157
111
107
38
Income Tax
29
49
57
41
232
2
Consolidated Net Income
73
78
100
69
340
36
Net Income
73
78
100
69
340
36
Net Income After Extraordinaries
73
78
100
69
340
36
Net Income Available to Common
73
78
100
69
340
36
EPS (Basic)
1.39
1.49
1.88
1.30
6.34
0.69
Basic Shares Outstanding
52
52
53
53
53
52
EPS (Diluted)
1.39
1.49
1.88
1.30
6.34
0.69
Diluted Shares Outstanding
52
53
53
53
54
52
EBITDA
204
241
288
304
356
332
Non-Operating Interest Income
-
-
-
-
-
-

About Prestige Brands Holdings

View Profile
Address
660 White Plains Road
Tarrytown New York 10591
United States
Employees -
Website http://www.prestigebrands.com
Updated 07/08/2019
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American Over-the-Counter (OTC) Healthcare, International OTC Healthcare, and Household Cleaning. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.